GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine
About GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine
Kharkiv National Medical University, formerly known as Kharkiv Medical Institute and previously Kharkiv State Medical University, is a medical university in Kharkiv, Ukraine. In March 2022 many buildings were heavily damaged due to the Russian invasion into Ukraine.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
Eli Lilly and Company
4
Galapagos NV
4
Celgene
3
Hoffmann-La Roche
3
Allergan
2
Genentech, Inc.
2
Janssen Research & Development, LLC
2
Daiichi Sankyo, Inc.
1
EMD Serono Research & Development Institute, Inc.
1
Gilead Sciences
1
Clinical Trials at GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine
During the past decade, GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 19 clinical trials were completed, i.e. on
average, 73.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 14 clinical trials were completed. i.e. 466.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina
2012-08-01
2016-12-01
Completed
1,004
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Patients
2014-02-25
2023-01-19
Completed
739
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
2015-01-26
2016-10-18
Completed
645
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
2014-11-14
2020-05-25
Completed
358
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
2015-03-20
2021-09-07
Completed
1,035
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
2015-06-17
2020-06-17
Completed
1,012
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Eli Lilly and Company" with 4 trials
sponsored, "Galapagos NV" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Hoffmann-La Roche"
with 3 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine"
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine
According to Clinical.Site data, the most researched conditions in "GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine" are
"Ulcerative Colitis" (9 trials), "Rheumatoid Arthritis" (6 trials), "Crohn Disease" (3 trials), "Arthritis, Rheumatoid" (2 trials) and "Diabetes Mellitus" (2 trials). Many other conditions were trialed in "GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine" in a lesser frequency.
Clinical Trials Intervention Types at GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine
Most popular intervention types in "GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine" are "Drug" (31 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (18 trials), "Filgotinib" (4 trials), "Etrolizumab" (3 trials), "Adalimumab" (2 trials) and "BI 695501" (2 trials). Other intervention names were less common.
Clinical Trials Genders at GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine
The vast majority of trials in "GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine" are
30 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine
Currently, there are NaN active trials in "GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine".
undefined are not yet recruiting,
2 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".